Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide
Glioblastoma (GBM) is the most common malignant primary brain tumor, and GBM patients have a poor overall prognosis. CDC20 expression is increased in a variety of tumors and associated with temozolomide (TMZ) resistance in glioma cells. Apcin specifically binds to CDC20 to inhibit APC/C-CDC20 intera...
Guardado en:
Autores principales: | Yiming Ding, Chuanbao Zhang, Lei He, Xinyu Song, Chengjun Zheng, Yuchu Pan, Shuqing Yu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8068b882860c4b75a9f0f754d9266177 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway
por: Xingming Zhong, et al.
Publicado: (2021) -
Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated <i>MGMT</i>
por: María del Mar Álvarez-Torres, et al.
Publicado: (2021) -
Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma
por: Kum Hee Noh, et al.
Publicado: (2022) -
MicroRNA-485-5p inhibits glioblastoma progression by suppressing E2F transcription factor 1 under cisplatin treatment
por: Conggang Huang, et al.
Publicado: (2021) -
A Systematic Review and Meta-Analysis on the Number of Adjuvant Temozolomide Cycles in Newly Diagnosed Glioblastoma
por: Fahimeh Attarian, et al.
Publicado: (2021)